Dr. Gunosewoyo’s long term research interests involve the rational drug design and development of key cellular targets to treat neurodegenerative and infectious diseases. His academic background in the School of Chemistry, University of Sydney, Australia sets up a strong foundation for multidisciplinary chemical biology research, including molecular biotechnology, organic chemistry, pharmacology, and synthetic medicinal chemistry. His pre-doctoral research under the supervision of Prof. Michael Kassiou and A/Prof. Mark Coster focuses on the use of novel polycarbocyclic compounds as P2X7 inhibitors for use in treatment of neurodegenerative diseases. Following his PhD, he joined Dr. Kozikowski’s group as a postdoc at the University of Illinois at Chicago, where he has been working on the design and synthesis of novel glycogen synthase kinase-3beta inhibitors to name a few. He is also involved in the synthesis of huperzine A analogs for protection against nerve agents-induced seizure/neurodegeneration and development of novel antitubercular agents derived from high throughput screening. HeĀ  is currently a Lecturer in the School of Pharmacy at Curtin University, Australia.


Hendra Gunosewoyo

Assistant Professor


  • DEPARTMENTDepartment of health sciences
    Curtin University
  • COUNTRYAustralia